top of page

Poster 49


Bimekizumab early treatment response translates into cumulative benefits in health-related quality of life in patients with moderate to severe plaque psoriasis: Pooled results from three multicenter, randomized, double-blinded phase 3 trials

Authors: Kenneth B. Gordon, Michael Sebastian, Steven R. Feldman, Paolo Eusebi, Krista Wixted, Cynthia Madden, Natalie Nunez Gomez, Valerie Ciaravino, Marc Radtke


POSTER 49

< PREVIOUS POSTER NEXT POSTER >


8 views

QUESTIONS, COMMENTS, & SURVEY

Please Rate This PosterPoorFairGoodVery goodExcellentPlease Rate This Poster
Thank you for submitting your feedback!

Search by Poster Number

Topics_Poster_Sq_10.jpg
Topics_Poster_Sq_11.jpg
Topics_Poster_Sq_12.jpg
Topics_Poster_Sq_13.jpg
Topics_Poster_Sq_14.jpg
Topics_Poster_Sq_15.jpg
Topics_Poster_Sq_16.jpg
bottom of page